Abstract:Objective To determine the morbidity of cervical intraepithelial neoplasia 2+(CIN2+) and CIN3+of different human papillomavirus(HPV)subtype infection combined with different cytology status.Methods The Shenzhen Cervical Cancer Screening Trial Ⅰ & Ⅱ(SHENCCASTⅠ&Ⅱ)are population-based cross-sectional cervical cancer screening studis conducted in Shenzhen and surrounding area from 2008 to2010.A total of 12 097 women who aged 25-59 years were included in the analysis.All of these women were detected by liquid-based cytology test and several high-risk HPV-DNA tests.The ones with HPV positive or atypical squamous cells of undetermined sign(ASC-US)were sequentially conducted by cervical biopsy vaginoscopy.Finally,10 805 samples with complete data of hybrid capture 2(HC2),the polymerase chain reaction-based matrix-assisted laser desorption/ionization time-of-flight assay(MALDI-TOF), HPV genotyping detection,cytology and pathology results were analyzed.Results The top 6 infection rates of HR-HPV in CIN2+and CIN3+were HPV16, HPV52, HPV58, HPV33, HPV31, HPV18.The highest constituent ratio of cytology in CIN 2+and CIN3+was high grade squamous intraepithelial lesion(HSIL).The morbidities of CIN2+of patients infected with HPV16, HPV31, HPV58, HPV33, HPV18, HPV52 were 41.3%, 31.5%, 30.6%, 28.7%, 28.2%, 17.7 %, respectively, while the morbidities of CIN3+of those were 33.5 %,20.5%, 19.4%, 15.7%, 19.2%,8.3%, respectively.The morbidities of CIN2+in negative intraepithelial lesion or malignancy(NILM),ASC-US, low grade squamous intraepithelial lesion(LSIL), atypical squamous cell cannot exclude high-grade squamous intraepithelial lesion(ASC-H), high grade squamous intraepithelial lesion(HSIL), atypical glandular cell(AGC)samples were 0.4%, 6.9%, 11.1%,36.4%,82.0%,16.7%,respectively,while the morbidities of CIN3+of those were 0.2%,3.1%, 4.2%,22.7%, 64.8%, 0.0%, respectively.The morbidities of CIN2+in NILM combined with HPV16, HPV18,HPV31, HPV33 infection were 12.6%, 13.3%, 15.8% and 11.5%, respectively, while the morbidities of CIN3+of those were 10.3%,11.1%,7.9%and 7.7%,respectively.The morbidities of CIN2+and CIN3+in ASC-US combining with hrHPV infection were high, and the top 6 subtypes associated with high risk of CIN2+were HPV31(35.7%), HPV33(26.9%), HPV16(26.5%), HPV58(22.4%), HPV52(18.6%), HPV68(15.4%), while those associated with high risk of CIN 3+were HPV16 (20.4%),HPV31(14.3%),HPV33(11.5%), HPV58(8.6%), HPV68(7.7%), HPV52(5.8%). Conclusions Cytology combined with HPV genotyping detection can more effectively estimate the morbidity risks of CIN2+and CIN3+.Both high prevalence rates and high risks associated with CIN 2+and CIN3+of HPV31,HPV33,HPV52 and HPV58 are observed.NILM and ASC-US status combined with these subtypes mentioned above are advised to be conducted by colposcopy.

Predictive Value of Various Atypical Cells for the Detection of Human Papillomavirus in Cervical Smears

Clinical Significance of Genotyping for Human Papillomavirus (HPV) 16 18/45 Combined with Cytology in Cervical Exfoliated Cells in HPV Oncogenic Mrna-Positive Women

Use of High-Risk Human Papiilomavirus DNA Testing to Deal with Atypical Squamous Cells-Can-not Exclude HSIL

Human Papillomavirus Genotyping to Predict the Risk of Cervical Precancerous Lesions or Cancer in Women with Minor Abnormal Cytology in China.

Genotype profile of HPV in ASC-H cytology and histologic follow-up-prevalence, distribution, and risk: A retrospective study of 1414 cases

The significance of extensive HPV genotyping for cervical high-grade neoplasia among women with atypical glandular cells

[Use of High-Risk Human Papillomavirus DNA Testing to Deal with Atypical Squamous Cells Undetermined Significance and Low Squamous Intraepithelial Lesion].

Role of Cytological Test for Cervices to Identify Human Papillomavirus in the Screening Program on Serious Cervical Lesion

Diagnostic value of high-risk HPV other than type 16/18 in high-grade cervical neoplasia among cytology-negative women: A multicenter retrospective study

Clinicopathological Implications of Human Papilloma Virus (HPV) L1 Capsid Protein Immunoreactivity in HPV16-Positive Cervical Cytology

Molecular Pap Smear: Validation of HPV Genotype and Host Methylation Profiles of ADCY8, CDH8, and ZNF582 as a Predictor of Cervical Cytopathology

High-Risk Genotypes of Human Papillomavirus at Diverse Anogenital Sites among Chinese Women: Infection Features and Potential Correlation with Cervical Intraepithelial Neoplasia

Clinical efficacy of human papillomavirus (HPV) genotyping in screening for cervical disorders

The Clinical Value Of T Lymphocyte Subsets And Nk Cells In Peripheral Blood Of Patients With High-Risk Hpv Infection And Different Cervical Lesions

Exploration of Treatment Strategies for Normal Cytology Smears with Reactive Cellular Changes

Human papillomavirus genotyping for predicting disease progression in women with biopsy-negative or cervical intraepithelial neoplasia grade 1 of low-grade intraepithelial lesion cytology

High-Risk Human Papillomavirus Dna Testing And High-Grade Cervical Intraepithelial Lesions

Association of human papillomavirus genotype distribution and cervical cytology: a cross-sectional study

Evaluation of CIN2+/CIN3+risk of Different HPV Subtypes Infection Combined with Abnormal Cytology Status

Optimal Papanicolaou Smear Conditions for Manual Microdissection of Single Target Cells

The Influence of Human Papillomavirus Genotypes on Visual Screening and Diagnosis of Cervical Precancer and Cancer.